We found 3 result(s) matching your search for 'Immunosuppression'. Search again?
- Immunosuppression
- The suppression of the immune response, usually with medications, to prevent the rejection of a transplanted organ or tissue. Medications commonly used to suppress the immune system after transplantation include prednisone, methylprednisolone, azathioprine, mycophenalate mofetil, cyclosporine, tacrolimus, and rapamycin, among others.
- Induction Therapy
- The administration of a brief course of high-dose immunosuppression in the early posttransplant period. Induction therapy precedes and overlaps with less intense long-term maintenance immunosuppression.
- Tumor
- An abnormal growth of tissue resulting from an uncontrolled multiplying of cells that serves no physiological function. Tumors can be either malignant (cancerous) or benign (non-cancerous). Malignant tumors include newly developed or de novo solid tumors as well as recurrent tumors that had previously been successfully treated. Posttransplant lymphoproliferative disorders (PTLD) are abnormal accumulations of immune cells brought about by the immunosuppression therapies used to reduce organ rejection.
Available Terms:
ABO Blood Type
Actual Donor
Additional Donor
Advisory Committee on Organ Transplantation (ACOT)
Allocation Policies
Allograft
Annual Death Rate
Antibody
Antigen
Cadaveric Donor
Cadaveric Transplant
Cardiomyopathy
Censoring
Centers for Medicare and Medicaid Services (CMS)
Chimerism
Cockcroft-Gault Formula
Cohort
Cold Ischemia Time (CIT)
Compliance
Confidence Interval
Congenital Heart Disease
Coronary Artery Disease
Creatinine
Crossmatch
Death Rate
Deceased Donor
Division of Transplantation (DoT)
Donation Rate
Donation Service Area
Donor
Donor Cardiac Death (DCD)
DSA
DSA
Eligible Donor
Emphysema
End-Stage Organ Failure
End-Stage Renal Disease (ESRD)
Ethnicity
Expanded Criteria Donor (ECD)
Expanded Criteria Donor (ECD) Kidneys
FEV1
Final Rule
Glomerular Filtration Rate (GFR)
Graft
Graft Survival
Haplotype
HCFA
Health Resources and Services Administration (HRSA)
Heterotopic Transplant
Histocompatibility Antigens
Human Leukocyte Antigen System (HLA System)
Immunogenicity
Immunosuppression
Induction Therapy
Informed Consent
Inotropes
Justice
Living Donor
Median Time to Transplant
Median Waiting Time
Medical Urgency Status Codes
Medical Urgency Status Codes for Heart Allocation (1999-2002)
Medical Urgency Status Codes for Heart Allocation (Pre-1999)
Medical Urgency Status Codes for Liver Allocation (1997)
Medical Urgency Status Codes for Liver Allocation (1997-2000)
Medical Urgency Status Codes for Liver Allocation (Pre-1997)
Mismatch
Model for End-Stage Liver Disease (MELD)
National Organ Transplant Act (NOTA)
Nonheartbeating Donor
OPO
Organ Preservation
Organ Procurement
Organ Procurement and Transplantation Network (OPTN)
Organ Procurement Organization (OPO)
Panel Reactive Antibody (PRA)
Patient Survival
Pediatric End Stage Liver Disease (PELD) Scoring System
Percentile
Procurement
Race
Recipient
Rejection
Scientific Registry of Transplant Recipients (SRTR)
Sensitization
Standard Error
Thoracic Organs
Time to Transplant (TT)
Tissue Type
Transplant Center
Transplant Program
Tumor
United Network for Organ Sharing (UNOS)
University Renal Research and Education Association (URREA)
Utility
Vascular
Ventricular Assist Device (VAD)
Waiting List
Waiting List (Active)
Waiting List (Inactive)
Waiting List (Removal)
Waiting Time